BSF Enterprise Plc (BSFA) - Net Assets
Based on the latest financial reports, BSF Enterprise Plc (BSFA) has net assets worth GBX2.72 Million GBX (≈ $330.69 USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX3.01 Million ≈ $365.85 USD) and total liabilities (GBX289.02K ≈ $35.16 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BSF Enterprise Plc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX2.72 Million |
| % of Total Assets | 90.39% |
| Annual Growth Rate | 31.86% |
| 5-Year Change | 645.0% |
| 10-Year Change | N/A |
| Growth Volatility | 332.83 |
BSF Enterprise Plc - Net Assets Trend (2019–2025)
This chart illustrates how BSF Enterprise Plc's net assets have evolved over time, based on quarterly financial data. See BSF Enterprise Plc (BSFA) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for BSF Enterprise Plc (2019–2025)
The table below shows the annual net assets of BSF Enterprise Plc from 2019 to 2025. For live valuation and market cap data, see BSF Enterprise Plc (BSFA) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | GBX2.72 Million ≈ $330.69 |
-14.81% |
| 2024-09-30 | GBX3.19 Million ≈ $388.18 |
-34.34% |
| 2023-09-30 | GBX4.86 Million ≈ $591.20 |
+35.61% |
| 2022-09-30 | GBX3.58 Million ≈ $435.94 |
+882.13% |
| 2021-09-30 | GBX364.82K ≈ $44.39 |
-13.78% |
| 2020-09-30 | GBX423.14K ≈ $51.48 |
-18.15% |
| 2019-09-30 | GBX516.99K ≈ $62.90 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BSF Enterprise Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 519348200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX1.28 Million | 47.23% |
| Other Comprehensive Income | GBX59.26K | 2.18% |
| Other Components | GBX6.66 Million | 245.15% |
| Total Equity | GBX2.72 Million | 100.00% |
BSF Enterprise Plc Competitors by Market Cap
The table below lists competitors of BSF Enterprise Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ordinary Fully Paid Deferred Settlement
AU:BCNDA
|
$15.36K |
|
Fantasy Network Ltd
TA:FNTS
|
$15.45K |
|
LungLife AI Inc
LSE:LLAI
|
$15.48K |
|
Endor AG
MU:E2N
|
$15.50K |
|
CRESTVIEW EXPLORATION INC
F:CE7
|
$14.74K |
|
SMCG Co., Ltd.
KQ:460870
|
$14.73K |
|
Acheter Louer
PA:ALALO
|
$14.46K |
|
AGROSERV MARIUTA
RO:MILK
|
$14.38K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BSF Enterprise Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,190,382 to 2,717,879, a change of -472,503 (-14.8%).
- Net loss of 1,113,527 reduced equity.
- New share issuances of 641,750 increased equity.
- Other comprehensive income increased equity by 20,779.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-1.11 Million | -40.97% |
| Share Issuances | GBX641.75K | +23.61% |
| Other Comprehensive Income | GBX20.78K | +0.76% |
| Other Changes | GBX-21.50K | -0.79% |
| Total Change | GBX- | -14.81% |
Book Value vs Market Value Analysis
This analysis compares BSF Enterprise Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 43.81x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 3.20x to 43.81x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-09-30 | GBX0.31 | GBX0.98 | x |
| 2020-09-30 | GBX0.25 | GBX0.98 | x |
| 2021-09-30 | GBX0.22 | GBX0.98 | x |
| 2022-09-30 | GBX0.95 | GBX0.98 | x |
| 2023-09-30 | GBX0.62 | GBX0.98 | x |
| 2024-09-30 | GBX0.37 | GBX0.98 | x |
| 2025-09-30 | GBX0.02 | GBX0.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BSF Enterprise Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -40.97%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2107.36%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 1.11x
- Recent ROE (-40.97%) is below the historical average (-29.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -18.26% | 0.00% | 0.00x | 1.07x | GBX-146.10K |
| 2020 | -22.20% | 0.00% | 0.00x | 1.08x | GBX-136.25K |
| 2021 | -16.02% | 0.00% | 0.00x | 1.10x | GBX-94.91K |
| 2022 | -25.96% | 0.00% | 0.00x | 1.13x | GBX-1.29 Million |
| 2023 | -30.89% | -11598.22% | 0.00x | 1.08x | GBX-1.99 Million |
| 2024 | -52.42% | -2892.19% | 0.02x | 1.10x | GBX-1.99 Million |
| 2025 | -40.97% | -2107.36% | 0.02x | 1.11x | GBX-1.39 Million |
Industry Comparison
This section compares BSF Enterprise Plc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $3,305,365
- Average return on equity (ROE) among peers: -653.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BSF Enterprise Plc (BSFA) | GBX2.72 Million | -18.26% | 0.11x | $15.23K |
| 4BASEBIO UK SOCIETAS (4BB) | $-492.00K | 0.00% | 0.00x | $989.13K |
| Aptamer Group PLC (APTA) | $8.05 Million | -26.00% | 0.43x | $155.87K |
| Arecor Therapeutics PLC (AREC) | $6.45 Million | 10.29% | 0.26x | $287.12K |
| Avacta Group PLC (AVCT) | $21.00K | -5252.38% | 9.24x | $3.91 Million |
| Bioventix (BVXP) | $6.58 Million | 38.84% | 0.05x | $1.16 Million |
| Cizzle Biotechnology Holdings PLC (CIZ) | $937.00K | -418.46% | 0.23x | $137.45K |
| Amur Minerals Corporation (CRTX) | $22.23 Million | -6.94% | 0.04x | $64.52K |
| Fusion Antibodies PLC (FAB) | $1.12 Million | -231.17% | 0.84x | $165.94K |
| Faron Pharmaceuticals Oy (FARN) | $-15.16 Million | 0.00% | 0.00x | $602.85K |
About BSF Enterprise Plc
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom.